Patent Reform: Senate May Amend Two Provisions In House Bill
Executive Summary
The Senate will vote on whether to limit debate on the House-passed patent reform bill when it reconvenes on Sept. 6. Senate Majority Leader Harry Reid, D-Nev., made a motion for the cloture vote before the August recess in hopes of getting a final bill through Congress quickly.
You may also be interested in...
Drug Importation Is A High-Profile Addition To US FDA’s Regulatory Agenda
Agency is targeting January 2020 for release of controversial proposed rule to allow importation of certain types of prescription drugs from Canada; although most Rx drug-related proposed and final rules on the Fall 2019 regulatory agenda are making repeat appearances, a final rule on electronic distribution of prescribing information has fallen off the list.
It's All Over But The Signing: Patent Reform Bill Passes Senate Without Amendments
Senate tables an amendment that would have scuttled the House compromise on PTO fee diversion, keeps intact provision extending time to file for patent term extension.
It's All Over But The Signing: Patent Reform Bill Passes Senate Without Amendments
Senate tables an amendment that would have scuttled the House compromise on PTO fee diversion, keeps intact provision extending time to file for patent term extension.